Clinical Trial Update: The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial investigates whether omeprazole can protect against oxaliplatin-induced peripheral neuropathy in cancer patients; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Omeprazole (Omeprazole)

Snippet

Sponsor: Aya Mohamed Sadek Elsaid | Conditions: Chemotherapy Induced Peripheral Neuropathy | Phase 3 | Status: COMPLETED